Usefulness of Dapagliflozin for Nephrotic Syndrome Secondary to Diabetic Kidney Disease

Intern Med. 2022 Dec 15;61(24):3699-3702. doi: 10.2169/internalmedicine.9121-21. Epub 2022 Apr 23.

Abstract

An 81-year-old woman with a medical history of type 2 diabetes mellitus and diabetic nephropathy was admitted with a diagnosis of multiple cerebellar infarctions. Proteinuria and leg edema were observed on the day after admission and diagnosed as nephrotic syndrome. Furosemide and spironolactone were started but showed no diuretic effect, and the renal function deteriorated. These agents were then replaced with dapagliflozin, which resulted in a positive diuretic effect and subsequent improvement of hypoalbuminemia and renal dysfunction. This case report demonstrates the utility of dapagliflozin for nephrotic syndrome to achieve a positive diuretic effect and improve hypoalbuminemia without deteriorating the renal function.

Keywords: dapagliflozin; diabetic nephropathy; nephrotic syndrome; sodium-glucose cotransporter 2 (SGLT2) inhibitor.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Benzhydryl Compounds / therapeutic use
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetic Nephropathies* / complications
  • Diabetic Nephropathies* / drug therapy
  • Diuretics
  • Female
  • Humans
  • Hypoalbuminemia*
  • Kidney
  • Nephrotic Syndrome* / complications
  • Nephrotic Syndrome* / drug therapy

Substances

  • dapagliflozin
  • Benzhydryl Compounds
  • Diuretics